After one year of treatment with the CFTR modulators elexacaftor-tezacaftor-ivacaftor, patients with cystic fibrosis ... A new analysis suggests that long-term exposure to air pollution poses a significant risk to the heart and lung heath of ... The Wake Forest Institute for Regenerative Medicine (WFIRM) has recently received a $24 million federal grant from the ... The U.S. Food and Drug Administration (FDA) issued a warning that three breast cancer drugs, Ibrance® (palbociclib), ... Recent research from Cedars-Sinai shows that a protein associated with cancer growth may play a role in developing ... Patients with diffuse cutaneous systemic sclerosis (SSc) who experience progressive skin fibrosis may be at an increased ... The National Institute for Health and Care Excellence (NICE) has shared new guidelines pertaining to the diagnosis and ... Midlife lung disease and impaired lung function may be associated with dementia and cognitive impairment later in life, ... The U.S. Food and Drug Administration (FDA) has approved a new drug, Arikayce (amikacin liposome inhalation ... A deep learning algorithm more accurately diagnosed fibrotic lung diseases than a team of specialist thoracic ...